Axa
FRLN

Axa’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Axa’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,921
Closed -$562K – 1257
2021
Q4 		$562K Sell
18,921
-18,826
-50% -$769K ﹤0.01% 1014
2021
Q3 		$1.93M Buy
37,747
+697
+2% +$49.6K 0.01% 861
2021
Q2 		$4.53M Sell
37,050
-2
-0% -$311 0.01% 732
2021
Q1 		$6.84M Buy
37,052
+287
+0.8% +$68K 0.02% 623
2020
Q4 		$10.1M Buy
36,765
+155
+0.4% +$39K 0.03% 521
2020
Q3 		$8.57M Buy
+36,610
New +$9.18M 0.03% 504

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Axa's FRLN Position: Q1 2022 in Review

Axa sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 18,921 shares — an estimated $562K sold.

Axa first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $10.1M in Q4 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

  • Axa reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Axa sold 18,921 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $562K.
  • Axa first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
  • Axa's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $10.1M in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.